INSIGHTS ON DRUG DEVELOPMENT
-
Temperature Dependence On Reversed-Phase Separations
Column temperature critically affects the reversed-phase separation of fatty acid-modified GLP-1 RAs and impurities. Learn how precise control enhances resolution and reproducibility.
-
Support For Your Production Challenges
Ensure your manufacturing operations run smoothly and efficiently by collaborating with experts to tackle production, processing, or quality control issues.
-
Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow
Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.
-
Assessing The Success Of CRISPR Gene Therapies Using ddPCR Technology
Achieve high-fidelity results in gene therapy research. Discover how absolute quantification overcomes traditional limitations to provide the precision needed for validating CRISPR edits.
-
Method Development For Forced Degradation Of GLP-1 Agonist3/18/2026
Gain insight into how a systematic approach reveals impurity behavior, strengthens selectivity, and refines chromatographic conditions to build a reliable degradation method for a GLP‑1 agonist.
-
Best-In-Class Nanodevelopment Capabilities2/3/2025
A highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.
-
Fast And Scalable Fc Quantitation In Supernatants3/24/2025
In biopharmaceutical development, the Fc PAIA Titer assay offers a fast, cost-effective, and automatable solution for high-throughput Fc quantification to enhance efficiency, support research, and accelerate production advancements.
-
API Solubility And Dissolution Enhancement Via Formulation6/4/2025
Solubility and dissolution rate of an API are essential for effective oral drug absorption. Discover how these factors directly influence bioavailability, which determines how much and how quickly a drug enters circulation.
-
A CDMO Is The Nexus Between Green Chemistry And Commercialization2/24/2026
Modern R&D transforms sustainability from an optional add-on into a strategic optimization tool, enhancing cost-efficiency, speed to market, and process intensification for drug developers.
DRUG DEVELOPMENT SOLUTIONS
-
Evaluating small and large molecule therapeutics within cellular environments is essential to understanding their efficacy, potency, and safety within a complex biological system.
-
Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.
-
Waters series of chromatography columns and standards offer scientists the diverse range of chromatographic selectivities needed to help characterize today's biotherapeutics and biosimilars.
-
ÄKTA ready™ chromatography system 450 is a single-use liquid chromatography system.
-
AST’s line of table-top machines, GENiSYS® Lab, are ideal systems for drug product development and cGMP production applications. Each system is designed to automate the critical aseptic operations for vial, syringe and cartridge processing to reduce contamination risk and product variability. These table-top systems are engineered to have complete compatibility with cleanroom environments, including Laminar Air Flow Hoods, Bio-Safety Cabinets and aseptic isolators.